Skip to content

Clinical trials

Phase 2/3 Neoplasm Metastasis trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Phase: Phase 2/3 Country / region: United Kingdom Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20071
20121
20152
20211
20242
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Recruiting4
Active, not recruiting2
Suspended1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bellus Health Inc. - a GSK company1
BioNTech SE1
Bristol-Myers Squibb1
Eikon Therapeutics1
Exelixis1
Federation Francophone de Cancerologie Digestive1
Novartis Pharmaceuticals1
Pfizer1
Replimune, Inc.1
Sanofi1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis12
Neoplasms2
Pancreatic Neoplasms2
Adenoma, Islet Cell1
Amyloidosis1
Anorexia1
Arthritis, Rheumatoid1
Breast Neoplasms1
Cachexia1
Carcinoma, Transitional Cell1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.